EPA axes benefits from cost-benefit analysis for air pollution limits

The U.S. Environmental Protection Agency (EPA) is reportedly shifting its approach to cost-benefit analysis regarding air pollution regulations, according to a recent report by the New York Times. Internal emails and documents suggest that the agency plans to eliminate the quantification of health benefits associated with reducing air pollution. Traditionally, the EPA has compared the economic costs of implementing stricter pollution limits with the estimated health benefits that would arise from cleaner air. This change means that while the agency will continue to detail the financial implications of pollution control measures—such as the expenses of new equipment at power plants—it will only qualitatively describe the potential health improvements that come from these regulations. Cost-benefit analysis has long been a cornerstone of the EPA's regulatory framework. It allows for informed decisions about whether to tighten or loosen air quality standards by weighing the costs against the anticipated economic gains from improved public health. Calculating these health benefits can be complex, as it involves estimating healthcare costs and potential productivity losses due to health issues exacerbated by pollution. A particularly challenging aspect of this analysis is determining the monetary value of human health. This is often expressed through the concept known as the “value of a statistical life,” which estimates how much individuals are willing to pay for slight reductions in their mortality risk from health conditions linked to environmental pollutants. By providing a dollar figure for health benefits, this metric has historically helped balance against the costs of pollution control efforts, but its removal may significantly alter the decision-making landscape for air quality regulation.